Biosimilar and generic cancer drugs unlikely to bend cost curve in the USA
Bennett, Charles L, Sartor, Oliver A, Armitage, James O, Kantarjian, HagopVolume:
18
Language:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(16)30653-2
Date:
January, 2017
File:
PDF, 107 KB
english, 2017